Conservative treatment of endometriosis;Leczenie zachowawcze endometriozy-praca poglądowa

Ginekologia Polska

Volumn 83, Issue 3, 2012, Pages 209-213

  Drews, Krzysztof ^a   Barlik, Magdalena ^a   Łukaszewski, Tomasz ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Chronic illness; Endometriosis; Medical treatment; Women

Indexed keywords

CHRONIC DISEASE; ENDOMETRIOSIS; FEMALE; HUMAN; REVIEW;

CHRONIC DISEASE; ENDOMETRIOSIS; FEMALE; HUMANS;

EID: 84861652822     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Endometriosis: Diagnosis and Management. J Obstet Gynaecol Canada. 2010, 32, Suppl. 2, 1-33.
2. The ESHRE Guideline on Endometriosis 2008
3. Eskenazi B, Warner M. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997, 24, 235-258.
4. Ozkan S, Murk W, Arici A. Endometriosis and infertility: epidemiology and evidence-based treatments. Ann NY Acad Sci. 2008, 1127, 92-100.
5. Kowalczyńska L, Ferenc T, Wojciechowski M, [i wsp.]. Polimorfizm I/D genu ACE u polskich pacjentek z endometrioza{ogonek}. Giekol Pol. 2011, 82, 102-107.
6. Giudice L. Clinical practice. Endometriosis. N Engl J Med. 2010, 362, 2389-2398.
7. Treatment of pelvic pain associated with endometriosis. The Practice Committee of the American Society for Reproductive Medicine. Fertil Steril. 2006, 86, Suppl. 4, 156-160.
8. Marjoribanks J, Proctor M, Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst Rev. 2003, 4:CD001751
9. Duffy D, Stouffer R. Follicular administration of a cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys. Hum Reprod. 2002, 17, 2825-2831.
10. Moghissi K. Medical treatment of endometriosis. Clin Obstet Gynecol. 1999, 42, 620-632.
11. Vercellini P, Frontino G, De Giorgi O, [et al.]. Continous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhoea that does not respond to a cyclic pill regimen. Fertil Steril. 2003, 80, 560-563.
12. Coffee A, Sulai P, Kuehl T. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen. Contraception. 2007, 75, 444-449.
13. Harada T, Momoeda M, Taketani Y, [et al.]. Low-dose oral contraceptive pill for dysmenorrhoea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2008, 90, 1583-1588.
14. Banaszewska B, Spaczyński R, Ożegowska K, Pawelczyk L. Wpływ niskodawkowej tabletki antykoncepcyjnej na parametry kliniczne i metaboliczne u młodych kobiet z zespołem policystycznych jajników. Ginekol Pol. 2011, 82, 430-435.
15. Olive D. Medical therapy of endometriosis. Semin Reprod Med. 2003, 21, 209-222.
16. Vercellini P, Cortesi I, Crosignani P. Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil Steril. 1997, 68, 393-401.
17. Oettel M, Breitbarth H, Elger W, [et al.]. The pharmacological profile of dienogest. Eur J Contracept Reprod Health Care. 1999, 4, Suppl. 1, 2-13.
18. Kohler G, Faustmann T, Gerlinger C, [et al.]. A dose-ranging study to determine the efficacy and safety of 1, 2 and 4 mg of dienogest daily for endometriosis. Int J Gynaecol Obstet. 2010, 108, 21-25.
19. Foster R, Wilde M. Dienogest. Drugs. 1998, 56, 825-833.
20. Sasagawa S, Shimizu Y, Kami H, [et al.]. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids. 2008, 73, 222-231.
21. Okada H, Nakajima T, Yoshimura T, [et al.]. The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro. Mol Hum Reprod. 2001, 7, 341-347.
22. Nakamura M, Katsuki Y, Shibutania Y, Oikawa T. Dienogest, a synthetic steroid, suppresses both embryonic and tumor-cell-induced angiogenesis. Eur J Pharmacol. 1999, 386, 33-40.
23. Seitz C, Gerlinger C, Faustmann T, [et al.]. Safety of dienogest in the long-term treatment of endometriosis: a one-year, open-label, follow-up study. Fertil Steril. 2009, 92, 107.
24. Schweppe K. The place of dydrogesterone in the treatment of endometriosis and adenomyosis. Maturitas. 2009, 65, 23-27.
25. Triverdi P, Selvaraj K, Mahapatra P, [et al.]. Effective post-laparoscopic treatment of endometriosis with dydrogesterone. Gynecol Endocrinol. 2007, 23, 73-76.
26. Vercellini P, Aimi G, Panazza S, [et al.]. A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil Steril. 1999, 72, 505-508.
27. Behamondes L, Petta C, Fernandes A, Monteiro J. Use of levonogesterol-relesing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhoea. Contraception. 2007, 75, Suppl. 6, 134-149.
28. Selak V, Farquhar C, Prentice A, Singla A. Danazol for pelvic pain associated with endometriosis. Cochrane Data -base Syst Rev. 2007, 17, CD000068.
29. Cottreau C, Ness R, Modugno F, [et al.]. Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. Clin Cancer Res. 2003, 9, 5142-5144.
30. Razzi S, Luisi S, Calonaci F, [et al.]. Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Fertil Steril. 2007, 88, 789-794.
31. Sagsveen M, Farmer J, Prentice A, Breeze A. Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density. Cochrane Database Syst Rev. 2003, 4, CD001297.
32. Barbieri R. Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am J Obstet Gynecol. 1992, 166, 740-745.
33. Bulun S, Fang Z, Imir G, [et al.]. Aromatase and endometriosis. Semin Reprod Med. 2004, 22, 45-50.
34. Harada T, Momoeda M, Taketani Y, [et al.]. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, doubleblind, multicenter, controlled trial. Fertil Steril. 2009, 91, 675-681.
35. Kitawaki J, Kusuki I, Yamanaka K, Suganuma J. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain. Eur J Obstet Gynecol Reprod Biol. 2011, 157, 212-216.
36. Hefler L, Grimm C, van Trotsenburg M, [et al.]. Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study. Fertil Steril. 2005, 84, 1033-1036.
37. Ferrero S, Camerini G, Ragni N, [et al.]. Letrozole and norethisterone acetate in colorectal endometriosis. Eur J Obstet Gynecol Reprod Biol. 2010, 150, 199-202.